1 |
Scarano A, Laddomada B, Blando F, De Santis S, Verna G, Chieppa M, Santino A. The Chelating Ability of Plant Polyphenols Can Affect Iron Homeostasis and Gut Microbiota. Antioxidants 2023;12:630. [DOI: 10.3390/antiox12030630] [Reference Citation Analysis]
|
2 |
Chen Y, Li S, Yin M, Li Y, Chen C, Zhang J, Sun K, Kong X, Chen Z, Qian J. Isorhapontigenin Attenuates Cardiac Microvascular Injury in Diabetes via the Inhibition of Mitochondria-Associated Ferroptosis Through PRDX2-MFN2-ACSL4 Pathways. Diabetes 2023;72:389-404. [PMID: 36367849 DOI: 10.2337/db22-0553] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Matte A, Federti E, De Franceschi L. Erythrocyte pyruvate kinase activation in red cell disorders. Curr Opin Hematol 2023. [PMID: 36853806 DOI: 10.1097/MOH.0000000000000758] [Reference Citation Analysis]
|
4 |
Bernardo VS, Torres FF, da Silva DGH. FoxO3 and oxidative stress: a multifaceted role in cellular adaptation. J Mol Med (Berl) 2023;101:83-99. [PMID: 36598531 DOI: 10.1007/s00109-022-02281-5] [Reference Citation Analysis]
|
5 |
Ibrahim HA, Zakaria SS, El-Batch MM, El-Shanshory MR, Alrayes ZR, Kabel AM, Eldardiry SA. The Value of SIRT1/FOXO1 Signaling Pathway in Early Detection of Cardiovascular Risk in Children with β-Thalassemia Major. Biomedicines 2022;10. [PMID: 36289866 DOI: 10.3390/biomedicines10102601] [Reference Citation Analysis]
|
6 |
McIntyre RL, Liu YJ, Hu M, Morris BJ, Willcox BJ, Donlon TA, Houtkooper RH, Janssens GE. Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity. Ageing Res Rev 2022;78:101621. [PMID: 35421606 DOI: 10.1016/j.arr.2022.101621] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
7 |
Menon V, Lin M, Liang R, Arif T, Menon A, Breda L, Rivella S, Ghaffari S. Elevated p21 (CDKN1a) mediates β-thalassemia erythroid apoptosis but its loss does not improve β-thalassemic erythropoiesis.. [DOI: 10.1101/2022.03.03.482874] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
8 |
Ajoolabady A, Bi Y, McClements DJ, Lip GYH, Richardson DR, Reiter RJ, Klionsky DJ, Ren J. Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy. Pharmacol Res 2022;176:106072. [PMID: 35007709 DOI: 10.1016/j.phrs.2022.106072] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
9 |
Buks R, Dagher T, Rotordam M, Monedero Alonso D, Cochet S, Gautier E, Chafey P, Cassinat B, Kiladjian J, Becker N, Plo I, Egée S, El Nemer W. Altered Ca2+ Homeostasis in Red Blood Cells of Polycythemia Vera Patients Following Disturbed Organelle Sorting during Terminal Erythropoiesis. Cells 2021;11:49. [DOI: 10.3390/cells11010049] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
10 |
Ali S, Mumtaz S, Shakir HA, Khan M, Tahir HM, Mumtaz S, Mughal TA, Hassan A, Kazmi SAR, Sadia, Irfan M, Khan MA. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med 2021;:e1788. [PMID: 34738740 DOI: 10.1002/mgg3.1788] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
11 |
Secci R, Hartmann A, Walter M, Grabe HJ, Van der Auwera-Palitschka S, Kowald A, Palmer D, Rimbach G, Fuellen G, Barrantes I. Biomarkers of geroprotection and cardiovascular health: An overview of omics studies and established clinical biomarkers in the context of diet. Crit Rev Food Sci Nutr 2021;:1-21. [PMID: 34648415 DOI: 10.1080/10408398.2021.1975638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
12 |
Suriyun T, Kaewsakulthong W, Khamphikham P, Chumchuen S, Hongeng S, Fucharoen S, Sripichai O. Association of the Degree of Erythroid Expansion and Maturation Arrest with the Clinical Severity of β0-Thalassemia/Hemoglobin E Patients. Acta Haematol 2021;144:660-71. [PMID: 34535581 DOI: 10.1159/000518310] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
13 |
Xu T, Zhang X, Liu Y, Wang H, Luo J, Luo Y, An P. Effects of dietary polyphenol supplementation on iron status and erythropoiesis: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2021;114:780-93. [PMID: 33871598 DOI: 10.1093/ajcn/nqab068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
14 |
Grzywa TM, Nowis D, Golab J. The role of CD71+ erythroid cells in the regulation of the immune response. Pharmacol Ther 2021;228:107927. [PMID: 34171326 DOI: 10.1016/j.pharmthera.2021.107927] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
|
15 |
Matte A, Federti E, Kung C, Kosinski PA, Narayanaswamy R, Russo R, Federico G, Carlomagno F, Desbats MA, Salviati L, Leboeuf C, Valenti MT, Turrini F, Janin A, Yu S, Beneduce E, Ronseaux S, Iatcenko I, Dang L, Ganz T, Jung CL, Iolascon A, Brugnara C, De Franceschi L. The pyruvate kinase activator mitapivat reduces hemolysis and improves anemia in a β-thalassemia mouse model. J Clin Invest 2021;131:144206. [PMID: 33822774 DOI: 10.1172/JCI144206] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
|
16 |
Grzywa TM, Justyniarska M, Nowis D, Golab J. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development. Cancers (Basel) 2021;13:870. [PMID: 33669537 DOI: 10.3390/cancers13040870] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
17 |
Cotoraci C, Ciceu A, Sasu A, Hermenean A. Natural Antioxidants in Anemia Treatment. Int J Mol Sci 2021;22:1883. [PMID: 33668657 DOI: 10.3390/ijms22041883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
18 |
Mattè A, Federti E, Tibaldi E, Di Paolo ML, Bisello G, Bertoldi M, Carpentieri A, Pucci P, Iatchencko I, Wilson AB, Riccardi V, Siciliano A, Turrini F, Kim DW, Choi SY, Brunati AM, De Franceschi L. Tyrosine Phosphorylation Modulates Peroxiredoxin-2 Activity in Normal and Diseased Red Cells. Antioxidants (Basel) 2021;10:206. [PMID: 33535382 DOI: 10.3390/antiox10020206] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
19 |
Vazquez BN, Fernández-duran I, Vaquero A. Sirtuins in hematopoiesis and blood malignancies. Sirtuin Biology in Medicine 2021. [DOI: 10.1016/b978-0-12-814118-2.00020-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
20 |
Torres FF, Bernardo VS, Silva DGH, Okumura JV, Bonini-Domingos CR. Association of FOXO3 polymorphism (rs3800231) and clinical subphenotypes of beta thalassemic individuals. Hematol Transfus Cell Ther 2020:S2531-1379(20)31286-4. [PMID: 33309469 DOI: 10.1016/j.htct.2020.09.147] [Reference Citation Analysis]
|
21 |
Maria Sposi N. Oxidative Stress and Iron Overload in β-Thalassemia: An Overview. Beta Thalassemia 2020. [DOI: 10.5772/intechopen.90492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
22 |
Piriyakhuntorn P, Tantiworawit A, Phimphilai M, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N. Impact of iron overload on bone remodeling in thalassemia. Arch Osteoporos 2020;15:143. [PMID: 32929613 DOI: 10.1007/s11657-020-00819-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
23 |
Matte A, De Franceschi L. Oxidation and erythropoiesis. Curr Opin Hematol 2019;26:145-51. [PMID: 30855333 DOI: 10.1097/MOH.0000000000000495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
24 |
Terán MM, Mónaco ME, Lazarte SS, Haro C, Ledesma Achem E, Asensio NA, Issé BA. Genetic Regulation of Redox Balance in β-Thalassemia Trait. Hemoglobin 2020;44:122-7. [PMID: 32448013 DOI: 10.1080/03630269.2020.1765794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
25 |
Tibaldi E, Federti E, Matte A, Iatcenko I, Wilson AB, Riccardi V, Pagano MA, De Franceschi L. Oxidation Impacts the Intracellular Signaling Machinery in Hematological Disorders. Antioxidants (Basel) 2020;9:E353. [PMID: 32344529 DOI: 10.3390/antiox9040353] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
26 |
Kuhikar R, Khan N, Philip J, Melinkeri S, Kale V, Limaye L. Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy. Stem Cell Res Ther 2020;11:71. [PMID: 32075694 DOI: 10.1186/s13287-020-01603-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
|
27 |
Madkour LH. Antioxidants, Therapeutic Options, and Regulation of the Immune Responses. Nanoparticles Induce Oxidative and Endoplasmic Reticulum Stresses 2020. [DOI: 10.1007/978-3-030-37297-2_13] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
28 |
Zhang S, Ma Y, Feng J. Neuroprotective mechanisms of ε-viniferin in a rotenone-induced cell model of Parkinson's disease: significance of SIRT3-mediated FOXO3 deacetylation. Neural Regen Res 2020;15:2143-53. [PMID: 32394973 DOI: 10.4103/1673-5374.282264] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
|
29 |
Matte A, Federti E, Winter M, Koerner A, Harmeier A, Mazer N, Tomka T, Di Paolo ML, De Falco L, Andolfo I, Beneduce E, Iolascon A, Macias-Garcia A, Chen JJ, Janin A, Lebouef C, Turrini F, Brugnara C, De Franceschi L. Bitopertin, a selective oral GLYT1 inhibitor, improves anemia in a mouse model of β-thalassemia. JCI Insight 2019;4:130111. [PMID: 31593554 DOI: 10.1172/jci.insight.130111] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
30 |
Fibach E, Dana M. Oxidative Stress in β-Thalassemia. Mol Diagn Ther 2019;23:245-61. [PMID: 30484264 DOI: 10.1007/s40291-018-0373-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
|
31 |
El-beshlawy A, El-ghamrawy M. Recent trends in treatment of thalassemia. Blood Cells, Molecules, and Diseases 2019;76:53-8. [DOI: 10.1016/j.bcmd.2019.01.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
|
32 |
Kim SH, Lee EM, Han SY, Choi HS, Ryu KY, Baek EJ. Improvement of Red Blood Cell Maturation In Vitro by Serum-Free Medium Optimization. Tissue Engineering Part C: Methods 2019;25:232-42. [DOI: 10.1089/ten.tec.2019.0023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
33 |
Pallauf K, Chin D, Günther I, Birringer M, Lüersen K, Schultheiß G, Vieten S, Krauß J, Bracher F, Danylec N, Soukup ST, Kulling SE, Rimbach G. Resveratrol, lunularin and dihydroresveratrol do not act as caloric restriction mimetics when administered intraperitoneally in mice. Sci Rep 2019;9:4445. [PMID: 30872769 DOI: 10.1038/s41598-019-41050-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
|
34 |
Menon V, Ghaffari S. Transcription factors FOXO in the regulation of homeostatic hematopoiesis. Curr Opin Hematol 2018;25:290-8. [PMID: 29782339 DOI: 10.1097/MOH.0000000000000441] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
|
35 |
Mello FV, Land MGP, Costa ES, Teodósio C, Sanchez ML, Bárcena P, Peres RT, Pedreira CE, Alves LR, Orfao A. Maturation-associated gene expression profiles during normal human bone marrow erythropoiesis. Cell Death Discov 2019;5:69. [PMID: 30854228 DOI: 10.1038/s41420-019-0151-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
36 |
Beneduce E, Matte A, De Falco L, Mbiandjeu S, Chiabrando D, Tolosano E, Federti E, Petrillo S, Mohandas N, Siciliano A, Babu W, Menon V, Ghaffari S, Iolascon A, De Franceschi L. Fyn kinase is a novel modulator of erythropoietin signaling and stress erythropoiesis. Am J Hematol 2019;94:10-20. [PMID: 30252956 DOI: 10.1002/ajh.25295] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
|
37 |
Liang R, Menon V, Ghaffari S. Following Transcriptome to Uncover FOXO Biological Functions. Methods Mol Biol 2019;1890:219-27. [PMID: 30414157 DOI: 10.1007/978-1-4939-8900-3_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
38 |
Yang HC, Wang JY, Bu XY, Yang B, Wang BQ, Hu S, Yan ZY, Gao YS, Han SY, Qu MQ. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway. J Cell Physiol 2019;234:6783-800. [PMID: 30317578 DOI: 10.1002/jcp.27409] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
|
39 |
Bissinger R, Bhuyan AAM, Qadri SM, Lang F. Oxidative stress, eryptosis and anemia: a pivotal mechanistic nexus in systemic diseases. FEBS J. 2019;286:826-854. [PMID: 30028073 DOI: 10.1111/febs.14606] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 16.0] [Reference Citation Analysis]
|
40 |
Psatha N, Reik A, Phelps S, Zhou Y, Dalas D, Yannaki E, Levasseur DN, Urnov FD, Holmes MC, Papayannopoulou T. Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major. Mol Ther Methods Clin Dev 2018;10:313-26. [PMID: 30182035 DOI: 10.1016/j.omtm.2018.08.003] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 12.6] [Reference Citation Analysis]
|
41 |
Espinoza JL, Kurokawa Y, Takami A. Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies. Blood Rev 2019;33:43-52. [PMID: 30005817 DOI: 10.1016/j.blre.2018.07.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
42 |
Zhang Y, Paikari A, Sumazin P, Ginter Summarell CC, Crosby JR, Boerwinkle E, Weiss MJ, Sheehan VA. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells. Blood 2018;132:321-33. [PMID: 29884740 DOI: 10.1182/blood-2017-11-814335] [Cited by in Crossref: 28] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
|
43 |
Beneduce E, Matte A, De Falco L, Mbiandjeu T, Chiabrando D, Tolosano E, Federti E, Petrillo S, Mohandas N, Siciliano A, Babu A, Menon V, Ghaffari S, Iolascon A, De Franceschi L. Fyn is Involved in Erythropoietin Signaling Pathway and Interfaces Oxidation to Regulate Erythropoiesis.. [DOI: 10.1101/323873] [Reference Citation Analysis]
|
44 |
Matte A, De Falco L, Federti E, Cozzi A, Iolascon A, Levi S, Mohandas N, Zamo A, Bruno M, Lebouef C, Janin A, Siciliano A, Ganz T, Federico G, Carlomagno F, Mueller S, Silva I, Carbone C, Melisi D, Kim DW, Choi SY, De Franceschi L. Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis. Antioxid Redox Signal 2018;28:1-14. [PMID: 28793778 DOI: 10.1089/ars.2017.7051] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
|
45 |
Fibach E, Rachmilewitz EA. Pathophysiology and treatment of patients with beta-thalassemia - an update. F1000Res 2017;6:2156. [PMID: 29333256 DOI: 10.12688/f1000research.12688.1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
|
46 |
Moras M, Lefevre SD, Ostuni MA. From Erythroblasts to Mature Red Blood Cells: Organelle Clearance in Mammals. Front Physiol 2017;8:1076. [PMID: 29311991 DOI: 10.3389/fphys.2017.01076] [Cited by in Crossref: 142] [Cited by in F6Publishing: 146] [Article Influence: 23.7] [Reference Citation Analysis]
|
47 |
Truong VL, Jun M, Jeong WS. Role of resveratrol in regulation of cellular defense systems against oxidative stress. Biofactors 2018;44:36-49. [PMID: 29193412 DOI: 10.1002/biof.1399] [Cited by in Crossref: 170] [Cited by in F6Publishing: 173] [Article Influence: 28.3] [Reference Citation Analysis]
|
48 |
Thanuthanakhun N, Nuntakarn L, Sampattavanich S, Anurathapan U, Phuphanitcharoenkun S, Pornpaiboonstid S, Borwornpinyo S, Hongeng S. Investigation of FoxO3 dynamics during erythroblast development in β-thalassemia major. PLoS One 2017;12:e0187610. [PMID: 29099866 DOI: 10.1371/journal.pone.0187610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
49 |
Federti E, Matte A, Ghigo A, Andolfo I, James C, Siciliano A, Leboeuf C, Janin A, Manna F, Choi SY, Iolascon A, Beneduce E, Melisi D, Kim DW, Levi S, De Franceschi L. Data demonstrating the role of peroxiredoxin 2 as important anti-oxidant system in lung homeostasis. Data Brief 2017;15:376-81. [PMID: 29034295 DOI: 10.1016/j.dib.2017.09.062] [Reference Citation Analysis]
|
50 |
Oikonomidou PR, Rivella S. What can we learn from ineffective erythropoiesis in thalassemia? Blood Rev 2018;32:130-43. [PMID: 29054350 DOI: 10.1016/j.blre.2017.10.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
|
51 |
Stanslowsky N, Reinhardt P, Glass H, Kalmbach N, Naujock M, Hensel N, Lübben V, Pal A, Venneri A, Lupo F, De Franceschi L, Claus P, Sterneckert J, Storch A, Hermann A, Wegner F. Neuronal Dysfunction in iPSC-Derived Medium Spiny Neurons from Chorea-Acanthocytosis Patients Is Reversed by Src Kinase Inhibition and F-Actin Stabilization. J Neurosci 2016;36:12027-43. [PMID: 27881786 DOI: 10.1523/JNEUROSCI.0456-16.2016] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
|
52 |
Federti E, Matté A, Ghigo A, Andolfo I, James C, Siciliano A, Leboeuf C, Janin A, Manna F, Choi SY, Iolascon A, Beneduce E, Melisi D, Kim DW, Levi S, De Franceschi L. Peroxiredoxin-2 plays a pivotal role as multimodal cytoprotector in the early phase of pulmonary hypertension. Free Radic Biol Med 2017;112:376-86. [PMID: 28801243 DOI: 10.1016/j.freeradbiomed.2017.08.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
|
53 |
Egea J, Fabregat I, Frapart YM, Ghezzi P, Görlach A, Kietzmann T, Kubaichuk K, Knaus UG, Lopez MG, Olaso-Gonzalez G, Petry A, Schulz R, Vina J, Winyard P, Abbas K, Ademowo OS, Afonso CB, Andreadou I, Antelmann H, Antunes F, Aslan M, Bachschmid MM, Barbosa RM, Belousov V, Berndt C, Bernlohr D, Bertrán E, Bindoli A, Bottari SP, Brito PM, Carrara G, Casas AI, Chatzi A, Chondrogianni N, Conrad M, Cooke MS, Costa JG, Cuadrado A, My-Chan Dang P, De Smet B, Debelec-Butuner B, Dias IHK, Dunn JD, Edson AJ, El Assar M, El-Benna J, Ferdinandy P, Fernandes AS, Fladmark KE, Förstermann U, Giniatullin R, Giricz Z, Görbe A, Griffiths H, Hampl V, Hanf A, Herget J, Hernansanz-Agustín P, Hillion M, Huang J, Ilikay S, Jansen-Dürr P, Jaquet V, Joles JA, Kalyanaraman B, Kaminskyy D, Karbaschi M, Kleanthous M, Klotz LO, Korac B, Korkmaz KS, Koziel R, Kračun D, Krause KH, Křen V, Krieg T, Laranjinha J, Lazou A, Li H, Martínez-Ruiz A, Matsui R, McBean GJ, Meredith SP, Messens J, Miguel V, Mikhed Y, Milisav I, Milković L, Miranda-Vizuete A, Mojović M, Monsalve M, Mouthuy PA, Mulvey J, Münzel T, Muzykantov V, Nguyen ITN, Oelze M, Oliveira NG, Palmeira CM, Papaevgeniou N, Pavićević A, Pedre B, Peyrot F, Phylactides M, Pircalabioru GG, Pitt AR, Poulsen HE, Prieto I, Rigobello MP, Robledinos-Antón N, Rodríguez-Mañas L, Rolo AP, Rousset F, Ruskovska T, Saraiva N, Sasson S, Schröder K, Semen K, Seredenina T, Shakirzyanova A, Smith GL, Soldati T, Sousa BC, Spickett CM, Stancic A, Stasia MJ, Steinbrenner H, Stepanić V, Steven S, Tokatlidis K, Tuncay E, Turan B, Ursini F, Vacek J, Vajnerova O, Valentová K, Van Breusegem F, Varisli L, Veal EA, Yalçın AS, Yelisyeyeva O, Žarković N, Zatloukalová M, Zielonka J, Touyz RM, Papapetropoulos A, Grune T, Lamas S, Schmidt HHHW, Di Lisa F, Daiber A. European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS). Redox Biol 2017;13:94-162. [PMID: 28577489 DOI: 10.1016/j.redox.2017.05.007] [Cited by in Crossref: 194] [Cited by in F6Publishing: 201] [Article Influence: 32.3] [Reference Citation Analysis]
|
54 |
Ingoglia G, Sag CM, Rex N, De Franceschi L, Vinchi F, Cimino J, Petrillo S, Wagner S, Kreitmeier K, Silengo L, Altruda F, Maier LS, Hirsch E, Ghigo A, Tolosano E. Data demonstrating the anti-oxidant role of hemopexin in the heart. Data Brief 2017;13:69-76. [PMID: 28560284 DOI: 10.1016/j.dib.2017.05.026] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
55 |
Ingoglia G, Sag CM, Rex N, De Franceschi L, Vinchi F, Cimino J, Petrillo S, Wagner S, Kreitmeier K, Silengo L, Altruda F, Maier LS, Hirsch E, Ghigo A, Tolosano E. Hemopexin counteracts systolic dysfunction induced by heme-driven oxidative stress. Free Radic Biol Med 2017;108:452-64. [PMID: 28400318 DOI: 10.1016/j.freeradbiomed.2017.04.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
|
56 |
Lazarte SS, Mónaco ME, Terán MM, Haro AC, Achem MEL, Issé BA. Foxo3 gene expression and oxidative status in beta-thalassemia minor subjects. Rev Bras Hematol Hemoter 2017;39:115-21. [PMID: 28577647 DOI: 10.1016/j.bjhh.2017.01.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
57 |
Porreca I, D'Angelo F, De Franceschi L, Mattè A, Ceccarelli M, Iolascon A, Zamò A, Russo F, Ravo M, Tarallo R, Scarfò M, Weisz A, De Felice M, Mallardo M, Ambrosino C. Pesticide toxicogenomics across scales: in vitro transcriptome predicts mechanisms and outcomes of exposure in vivo. Sci Rep 2016;6:38131. [PMID: 27905518 DOI: 10.1038/srep38131] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
58 |
Makis A, Hatzimichael E, Papassotiriou I, Voskaridou E. 2017 Clinical trials update in new treatments of β-thalassemia. Am J Hematol 2016;91:1135-45. [PMID: 27502996 DOI: 10.1002/ajh.24530] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 6.0] [Reference Citation Analysis]
|
59 |
Lupo F, Tibaldi E, Matte A, Sharma AK, Brunati AM, Alper SL, Zancanaro C, Benati D, Siciliano A, Bertoldi M, Zonta F, Storch A, Walker RH, Danek A, Bader B, Hermann A, De Franceschi L. A new molecular link between defective autophagy and erythroid abnormalities in chorea-acanthocytosis. Blood 2016;128:2976-87. [PMID: 27742708 DOI: 10.1182/blood-2016-07-727321] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
|
60 |
Liang R, Ghaffari S. Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease. Br J Haematol 2016;174:661-73. [PMID: 27442953 DOI: 10.1111/bjh.14194] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
|
61 |
Theodorou A, Phylactides M, Forti L, Cramarossa MR, Spyrou P, Gambari R, Thein SL, Kleanthous M. The investigation of resveratrol and analogs as potential inducers of fetal hemoglobin. Blood Cells, Molecules, and Diseases 2016;58:6-12. [DOI: 10.1016/j.bcmd.2015.11.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
|
62 |
Lupo F, Russo R, Iolascon A, Ieluzzi D, Siciliano A, Toniutto P, Matté A, Piovesan S, Raffetti E, Turrini F, Dissegna D, Donato F, Alberti A, Zuliani V, Fattovich G, De Franceschi L. Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients. Liver Int 2016;36:49-58. [PMID: 26104535 DOI: 10.1111/liv.12900] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
|
63 |
Bellelli R, Federico G, Matte’ A, Colecchia D, Iolascon A, Chiariello M, Santoro M, De franceschi L, Carlomagno F. NCOA4 Deficiency Impairs Systemic Iron Homeostasis. Cell Reports 2016;14:411-21. [DOI: 10.1016/j.celrep.2015.12.065] [Cited by in Crossref: 113] [Cited by in F6Publishing: 122] [Article Influence: 16.1] [Reference Citation Analysis]
|
64 |
Matte A, De Falco L, Iolascon A, Mohandas N, An X, Siciliano A, Leboeuf C, Janin A, Bruno M, Choi SY, Kim DW, De Franceschi L. The Interplay Between Peroxiredoxin-2 and Nuclear Factor-Erythroid 2 Is Important in Limiting Oxidative Mediated Dysfunction in β-Thalassemic Erythropoiesis. Antioxid Redox Signal 2015;23:1284-97. [PMID: 26058667 DOI: 10.1089/ars.2014.6237] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
|
65 |
Rochette L, Zeller M, Cottin Y, Vergely C. Growth and differentiation factor 11 (GDF11): Functions in the regulation of erythropoiesis and cardiac regeneration. Pharmacology & Therapeutics 2015;156:26-33. [DOI: 10.1016/j.pharmthera.2015.10.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
|
66 |
Raj P, Aloud BM, Louis XL, Yu L, Zieroth S, Netticadan T. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats. J Nutr Biochem 2016;28:155-63. [PMID: 26878793 DOI: 10.1016/j.jnutbio.2015.09.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
|
67 |
Liang R, Campreciós G, Kou Y, McGrath K, Nowak R, Catherman S, Bigarella CL, Rimmelé P, Zhang X, Gnanapragasam MN, Bieker JJ, Papatsenko D, Ma'ayan A, Bresnick E, Fowler V, Palis J, Ghaffari S. A Systems Approach Identifies Essential FOXO3 Functions at Key Steps of Terminal Erythropoiesis. PLoS Genet 2015;11:e1005526. [PMID: 26452208 DOI: 10.1371/journal.pgen.1005526] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
|
68 |
Dalle Carbonare L, Matte' A, Valenti MT, Siciliano A, Mori A, Schweiger V, Zampieri G, Perbellini L, De Franceschi L. Hypoxia-reperfusion affects osteogenic lineage and promotes sickle cell bone disease. Blood 2015;126:2320-8. [PMID: 26330244 DOI: 10.1182/blood-2015-04-641969] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
|
69 |
Biala AK, Dhingra R, Kirshenbaum LA. Mitochondrial dynamics: Orchestrating the journey to advanced age. J Mol Cell Cardiol 2015;83:37-43. [PMID: 25918048 DOI: 10.1016/j.yjmcc.2015.04.015] [Cited by in Crossref: 56] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
|
70 |
Finotti A, Breda L, Lederer CW, Bianchi N, Zuccato C, Kleanthous M, Rivella S, Gambari R. Recent trends in the gene therapy of β-thalassemia. J Blood Med. 2015;6:69-85. [PMID: 25737641 DOI: 10.2147/jbm.s46256] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 1.6] [Reference Citation Analysis]
|
71 |
Ido Y, Duranton A, Lan F, Weikel KA, Breton L, Ruderman NB. Resveratrol prevents oxidative stress-induced senescence and proliferative dysfunction by activating the AMPK-FOXO3 cascade in cultured primary human keratinocytes. PLoS One 2015;10:e0115341. [PMID: 25647160 DOI: 10.1371/journal.pone.0115341] [Cited by in Crossref: 86] [Cited by in F6Publishing: 93] [Article Influence: 10.8] [Reference Citation Analysis]
|
72 |
Rimmelé P, Lofek-Czubek S, Ghaffari S. Resveratrol increases the bone marrow hematopoietic stem and progenitor cell capacity. Am J Hematol 2014;89:E235-8. [PMID: 25163926 DOI: 10.1002/ajh.23837] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
|
73 |
Zhang X, Campreciós G, Rimmelé P, Liang R, Yalcin S, Mungamuri SK, Barminko J, D'Escamard V, Baron MH, Brugnara C, Papatsenko D, Rivella S, Ghaffari S. FOXO3-mTOR metabolic cooperation in the regulation of erythroid cell maturation and homeostasis. Am J Hematol 2014;89:954-63. [PMID: 24966026 DOI: 10.1002/ajh.23786] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 6.7] [Reference Citation Analysis]
|
74 |
Matté A, Pantaleo A, Ferru E, Turrini F, Bertoldi M, Lupo F, Siciliano A, Ho Zoon C, De Franceschi L. The novel role of peroxiredoxin-2 in red cell membrane protein homeostasis and senescence. Free Radic Biol Med 2014;76:80-8. [PMID: 25151118 DOI: 10.1016/j.freeradbiomed.2014.08.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
|
75 |
Jung H, Choi I. Thioredoxin-interacting protein, hematopoietic stem cells, and hematopoiesis: . Current Opinion in Hematology 2014;21:265-70. [DOI: 10.1097/moh.0000000000000037] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
|
76 |
Finotti A, Gambari R. Recent trends for novel options in experimental biological therapy of β-thalassemia. Expert Opin Biol Ther 2014;14:1443-54. [PMID: 24934764 DOI: 10.1517/14712598.2014.927434] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
|
77 |
Coates TD. Physiology and pathophysiology of iron in hemoglobin-associated diseases. Free Radic Biol Med 2014;72:23-40. [PMID: 24726864 DOI: 10.1016/j.freeradbiomed.2014.03.039] [Cited by in Crossref: 92] [Cited by in F6Publishing: 98] [Article Influence: 10.2] [Reference Citation Analysis]
|
78 |
Yan H, Hu W, Zhang J, Wang Y, Xia K, Peng M, Liu J. Resveratrol induces human K562 cell apoptosis, erythroid differentiation, and autophagy. Tumor Biol 2014;35:5381-8. [DOI: 10.1007/s13277-014-1701-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
|
79 |
De Franceschi L, Bertoldi M, Matte A, Santos Franco S, Pantaleo A, Ferru E, Turrini F. Oxidative stress and β-thalassemic erythroid cells behind the molecular defect. Oxid Med Cell Longev 2013;2013:985210. [PMID: 24205432 DOI: 10.1155/2013/985210] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 3.9] [Reference Citation Analysis]
|